Sign in

CIK 0001468748

  • Non-accelerated filer
  • Smaller reporting company

Kodiak Sciences Inc.

Sign in to watch
Ticker
KOD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270476525
Phone
+1 650-281-0850
Business address
1250 PAGE MILL RD, PALO ALTO, CA, 94304
Former names
Oligasis, LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale See Remarks sold 3,487 shares at an average $7.09 ($24,708)
  6. 4 Open-market sale See Remarks sold 4,343 shares at an average $7.09 ($30,781)
  7. 4 Option exercise See Remarks acquired 2,900 shares (option exercise)
  8. 4 Option exercise See Remarks acquired 3,025 shares (option exercise)
  9. 4 Open-market buy Director bought 572,349 shares at an average $7.77 ($4,448,168)
  10. 4 Open-market buy Director bought 350,406 shares at an average $6.75 ($2,363,748)
  11. 4 Open-market buy Director bought 456,690 shares at an average $5.91 ($2,696,829)
  12. 4 Open-market sale Chairman and CEO sold 1,340,000 shares at an average $9.15 ($12,257,688)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Director bought 400,965 shares at an average $54.45 ($21,832,153)
  17. 4 Open-market buy Director bought 347,665 shares at an average $52.02 ($18,084,687)
  18. 4 Open-market buy Director bought 501,111 shares at an average $57.49 ($28,806,796)
  19. 4 Open-market sale See Remarks sold 6,950 shares at an average $64.39 ($447,494)
  20. 4 Open-market sale See Remarks sold 6,950 shares at an average $87.60 ($608,831)

Page 4 of 10 · 193 filings